Yu S - Search Results

1

NEAT1 promotes the malignant development of bladder cancer by regulating the miR-101/VEGF-C pathway in vitro and in vivo.

Zhang H, Yu S, Fei K, Huang Z, Deng S, Xu H. Zhang H, et al. Among authors: yu s. BMC Urol. 2022 Nov 25;22(1):193. doi: 10.1186/s12894-022-01151-z. BMC Urol. 2022. PMID: 36434587 Free PMC article.

2

MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.

Hong S, Yu S, Li J, Yin Y, Liu Y, Zhang Q, Guan H, Li Y, Xiao H. Hong S, et al. Among authors: yu s. Thyroid. 2016 Dec;26(12):1733-1743. doi: 10.1089/thy.2015.0578. Epub 2016 Nov 2. Thyroid. 2016. PMID: 27717302

3

MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.

Huang Y, Yu S, Cao S, Yin Y, Hong S, Guan H, Li Y, Xiao H. Huang Y, et al. Among authors: yu s. Thyroid. 2018 Sep;28(9):1162-1173. doi: 10.1089/thy.2017.0665. Epub 2018 Aug 21. Thyroid. 2018. PMID: 29882471

4

Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.

Chen L, Xiong L, Hong S, Li J, Huo Z, Li Y, Chen S, Zhang Q, Zhao R, Gingold JA, Zhu X, Lv W, Li Y, Yu S, Xiao H. Chen L, et al. Among authors: yu s. J Clin Endocrinol Metab. 2020 Aug 1;105(8):dgaa344. doi: 10.1210/clinem/dgaa344. J Clin Endocrinol Metab. 2020. PMID: 32492708

5

miR-3619-3p promotes papillary thyroid carcinoma progression via Wnt/β-catenin pathway.

Yu S, Cao S, Hong S, Lin X, Guan H, Chen S, Zhang Q, Lv W, Li Y, Xiao H. Yu S, et al. Ann Transl Med. 2019 Nov;7(22):643. doi: 10.21037/atm.2019.10.71. Ann Transl Med. 2019. PMID: 31930044 Free PMC article.

6

Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling.

Long L, Li Y, Yu S, Li X, Hu Y, Long T, Wang L, Li W, Ye X, Ke Z, Xiao H. Long L, et al. Among authors: yu s. J Diabetes Res. 2019 Dec 28;2019:4875421. doi: 10.1155/2019/4875421. eCollection 2019. J Diabetes Res. 2019. PMID: 31976335 Free PMC article.

7

STRA6 Promotes Thyroid Carcinoma Progression via Activation of the ILK/AKT/mTOR Axis in Cells and Female Nude Mice.

He W, Cheng Z, Huo Z, Lin B, Wang X, Sun Y, Yu S, Cao S, Xue J, Liu R, Lv W, Li Y, Hong S, Xiao H. He W, et al. Among authors: yu s. Endocrinology. 2023 Jan 9;164(3):bqac215. doi: 10.1210/endocr/bqac215. Endocrinology. 2023. PMID: 36592123

8

Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.

Zhang L, Yu S, Hong S, Xiao X, Liao Z, Li Y, Xiao H. Zhang L, et al. Among authors: yu s. BMC Med Genomics. 2023 Oct 5;16(1):234. doi: 10.1186/s12920-023-01676-8. BMC Med Genomics. 2023. PMID: 37798795 Free PMC article.

9

Exendin-4 inhibits growth and augments apoptosis of ovarian cancer cells.

He W, Yu S, Wang L, He M, Cao X, Li Y, Xiao H. He W, et al. Among authors: yu s. Mol Cell Endocrinol. 2016 Nov 15;436:240-9. doi: 10.1016/j.mce.2016.07.032. Epub 2016 Aug 3. Mol Cell Endocrinol. 2016. PMID: 27496641

10

MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1.

Cheng K, Feng L, Yu S, Yu C, Chi N. Cheng K, et al. Among authors: yu s, yu c. Onco Targets Ther. 2019 Dec 31;12:11737-11750. doi: 10.2147/OTT.S218876. eCollection 2019. Onco Targets Ther. 2019. Retraction in: Onco Targets Ther. 2021 Oct 01;14:4965-4966. doi: 10.2147/OTT.S341749 PMID: 32099382 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,953 results

Search Page

Filters